Anthropic has reportedly purchased Coefficient Bio, a stealth biotech AI startup, in a $400 million stock deal, according to reports from The Information and Eric Newcomer. The acquisition signals a significant move for Anthropic into the intersection of artificial intelligence and biotechnology.
Coefficient Bio, which has been operating under the radar, focuses on applying AI technologies to advance biotechnological research and development. The deal, structured as a stock transaction, reflects the high value Anthropic places on Coefficient Bio’s expertise and potential.
The acquisition details were initially reported by The Information and further corroborated by Eric Newcomer, highlighting the strategic importance of this acquisition for Anthropic as it looks to expand its capabilities and applications of AI in new and innovative fields. The move could potentially lead to new advancements in drug discovery, personalized medicine, and other biotech applications.